Quick answers
- What is Droxia?
- Droxia is a brand name of Hydroxyurea, a prescription medicine. The FDA NDC Directory lists 6 Droxia products in 3 strengths and forms.
- Who makes Droxia?
- Waylis Therap holds the FDA application for Droxia (NDA016295, approved December 7, 1967). 1 other company (repackagers or distributors) also list Droxia products.
- Is there a generic or store brand of Droxia?
- Other products of Hydroxyurea are listed with the FDA, but none in exactly the same strength and form as a Droxia product.
- Has Droxia been recalled?
- No recall linked to Droxia products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Droxia is
Each Droxia product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Hydroxyurea · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| hydroxyurea 200 mg capsule (oral) | Droxia | None listed | DailyMed |
| hydroxyurea 300 mg capsule (oral) | Droxia | None listed | DailyMed |
| hydroxyurea 400 mg capsule (oral) | Droxia | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Hydroxyurea →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA016295 | Waylis Therap | December 7, 1967 | 6 |
Companies that list Droxia
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Droxia products.
- H2-Pharma LLC3 products
- Waylis Therapeutics LLC3 products
Recalls
No recall linked to Droxia products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.